{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:58:30Z","timestamp":1790611110700,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cow\u2019s milk allergy (CMA) is the most common food allergy in infants, requiring the use of hypoallergenic formulas when breastfeeding is not possible. Hydrolysed rice formulas (HRF) are now positioned alongside extensively hydrolysed cow\u2019s milk protein formulas as first line (nutritional) management of CMA in both European and International guidelines. This descriptive single-arm, multicentre interventional study (NCT05618704) evaluated growth, safety, and tolerance of a new HRF in infants with CMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Infants \u22648\u202fmonths with CMA, diagnosed by their clinicians according to the local hospital practice, were recruited from clinics in Belgium, Poland and Spain. The infants (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f69) were prescribed the new HRF and followed for 16\u202fweeks. Adequate growth was assessed using WHO growth z-scores weight-for-age and weight-for-length. Allergic symptoms (assessed by the clinician using Cow\u2019s Milk-related Symptom Score [CoMiSS\u00ae]), gastrointestinal symptoms (reported in diaries by parents) and safety were monitored during the 16-week period. Growth and efficacy analyses were primarily conducted on infants who completed the 16-week observational period (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f61), with sensitivity analyses performed in the all subjects treated (AST) population. Safety analyses were conducted on all infants that consumed the HRF (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, mean age (\u00b1SD) was 3.17\u202f\u00b1\u202f2.32\u202fmonths. Over the 16-week period, increases in weight-for-age and weight-for-length were observed, with 92% of infants (56\/61) meeting the predefined criteria for adequate growth. Sensitivity analyses in the AST population yielded consistent conclusions. Cow\u2019s milk related symptoms decreased over time; mean CoMiSS declined from 11.3\u202f\u00b1\u202f3.4 at baseline to 2.1\u202f\u00b1\u202f1.8 at 16\u202fweeks, with reductions observed across all CMA diagnostic categories. Compared with baseline, parents reported reductions in gastrointestinal symptoms over the observation period. The overall parental opinion was that the formula was very good. No new safety signals were identified during the 16-week study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Infants with clinician-diagnosed CMA who received the new HRF for 16\u202fweeks showed adequate growth and reductions in cow\u2019s milk related and gastrointestinal symptoms over time. The formula was well tolerated by infants and well accepted by parents, and no new safety signals were observed during the study period. These findings support the use of HRF as a nutritional option for the dietary management of CMA, in line with current guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1892511","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:32:30Z","timestamp":1790609550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth, safety, and tolerance of a hydrolysed rice protein-based formula in infants with cow\u2019s milk allergy"],"prefix":"10.3389","volume":"13","author":[{"given":"Malgorzata","family":"Arciszewska","sequence":"first","affiliation":[{"name":"Poliklinika Ginekologiczno-Poloznicza Sp. z.o.o. Sp.K","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieslaw","family":"Olechowski","sequence":"additional","affiliation":[{"name":"Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o.","place":["Tarn\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Lirio Casero","sequence":"additional","affiliation":[{"name":"San Rafael Hospital","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Colinet","sequence":"additional","affiliation":[{"name":"CHC MontL\u00e9gia","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Cotton","sequence":"additional","affiliation":[{"name":"Danone Research and Innovation","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Oude Nijhuis","sequence":"additional","affiliation":[{"name":"Danone Research and Innovation","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the STORY study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/all.12630","article-title":"Incidence and natural history of challenge-proven cow's milk allergy in European children--EuroPrevall birth cohort","volume":"70","author":"Schoemaker","year":"2015","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/nu11051051","article-title":"Epidemiology of cow's Milk allergy","volume":"11","author":"Flom","year":"2019","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/pch\/pxae043","article-title":"Cow's milk protein allergy in infants and children","volume":"29","author":"Sathya","year":"2024","journal-title":"Paediatr Child Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00431-014-2422-3","article-title":"Cow's milk allergy: evidence-based diagnosis and management for the practitioner","volume":"174","author":"Lifschitz","year":"2015","journal-title":"Eur J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MPG.0b013e31825c9482","article-title":"Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI committee practical guidelines","volume":"55","author":"Koletzko","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/pai.12960","article-title":"Nutritional disorders resulting from food allergy in children","volume":"29","author":"Meyer","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/MPG.0000000000003897","article-title":"An ESPGHAN position paper on the diagnosis, management, and prevention of cow's milk allergy","volume":"78","author":"Vandenplas","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/all.12429","article-title":"EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"100613","DOI":"10.1016\/j.waojou.2021.100613","article-title":"World allergy organization (WAO) diagnosis and rationale for action against cow's Milk allergy (DRACMA) guidelines update - IV - a quality appraisal with the AGREE II instrument","volume":"15","author":"Strozyk","year":"2022","journal-title":"World Allergy Organ J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.waojou.2021.100609","article-title":"World allergy organization (WAO) diagnosis and rationale for action against cow's Milk allergy (DRACMA) guidelines update - I - plan and definitions","volume":"15","author":"Fiocchi","year":"2022","journal-title":"World Allergy Organ J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm11164823","article-title":"Hydrolyzed Rice formula: an appropriate choice for the treatment of cow's Milk allergy","volume":"11","author":"Anania","year":"2022","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3390\/nu12092654","article-title":"Hydrolyzed rice protein-based formulas, a vegetal alternative in cow's milk allergy","volume":"12","author":"Dupont","year":"2020","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/nu17010162","article-title":"Growth, safety and tolerance in infants fed rice protein hydrolysate formula: the GRITO randomised controlled trial","volume":"17","author":"Lemoine","year":"2024","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jpn3.12161","article-title":"Growth pattern of paediatric patients affected by cow milk protein allergy fed with rice hydrolyzed formula","volume":"78","author":"Nocerino","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1399-3038.2010.00991.x","article-title":"The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy","volume":"21","author":"Reche","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00431-014-2308-4","article-title":"Safety and tolerance of a new extensively hydrolyzed rice protein-based formula in the management of infants with cow's milk protein allergy","volume":"173","author":"Vandenplas","year":"2014","journal-title":"Eur J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3390\/nu16121863","article-title":"Tolerance of infants fed a hydrolyzed Rice infant formula with 2'-Fucosyllactose (2'-FL) human Milk oligosaccharide (HMO)","volume":"16","author":"Ramirez-Farias","year":"2024","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2222.2006.02428.x","article-title":"A hydrolysed rice-based formula is tolerated by children with cow's milk allergy: a multi-Centre study","volume":"36","author":"Fiocchi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.arcped.2019.03.001","article-title":"Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow's milk protein allergy","volume":"26","author":"Bocquet","year":"2019","journal-title":"Arch Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5223\/pghn.2021.24.3.316","article-title":"Growth patterns of Indonesian infants with cow's milk allergy and fed with soy-based infant formula","volume":"24","author":"Setiabudiawan","year":"2021","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/147323000303100308","article-title":"Nutritional value of a rice-hydrolysate formula in infants with cows' milk protein allergy: a randomized pilot study","volume":"31","author":"D'Auria","year":"2003","journal-title":"J Int Med Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1651-2227.2005.tb02166.x","article-title":"Z-score of weight for age of infants with atopic dermatitis and cow's milk allergy fed with a rice-hydrolysate formula during the first two years of life","volume":"94","author":"Savino","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/07315724.2006.10719509","article-title":"Growth, tolerance and biochemical measures in healthy infants fed a partially hydrolyzed rice protein-based formula: a randomized, blinded, prospective trial","volume":"25","author":"Lasekan","year":"2006","journal-title":"J Am Coll Nutr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.arcped.2012.12.002","article-title":"Growth and tolerance in infants fed an infant formula based on hydrolyzed rice proteins","volume":"20","author":"Girardet","year":"2013","journal-title":"Arch Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/archdischild-2013-304727","article-title":"An extensively hydrolysed rice protein-based formula in the management of infants with cow's milk protein allergy: preliminary results after 1 month","volume":"99","author":"Vandenplas","year":"2014","journal-title":"Arch Dis Child"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41390-022-02334-y","article-title":"Cow's milk-related symptom score for cow's milk allergy assessment: a meta-analysis for test accuracy","volume":"93","author":"Saad","year":"2023","journal-title":"Pediatr Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00365521.1997.11720714","article-title":"Modification of the intestinal microflora using probiotics and prebiotics","volume":"32","author":"Fuller","year":"1997","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/j.1536-4801.2002.tb07629.x","article-title":"Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants","volume":"34","author":"Moro","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00005176-200501000-00007","article-title":"Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants","volume":"40","author":"Knol","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1475-2891-6-8","article-title":"The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial","volume":"6","author":"Bongers","year":"2007","journal-title":"Nutr J"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1892511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:32:31Z","timestamp":1790609551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1892511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":30,"alternative-id":["10.3389\/fnut.2026.1892511"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1892511","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1892511"}}